- Home
- OUST vs PCRX Comparison
OUST vs PCRX Comparison
Compare OUST & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- PCRX
- Stock Information
- Founded
- OUST 2015
- PCRX 2006
- Country
- OUST United States
- PCRX United States
- Employees
- OUST N/A
- PCRX N/A
- Industry
- OUST Industrial Machinery/Components
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- PCRX Health Care
- Exchange
- OUST Nasdaq
- PCRX Nasdaq
- Market Cap
- OUST 1.1B
- PCRX 1.2B
- IPO Year
- OUST N/A
- PCRX 2011
- Fundamental
- Price
- OUST $23.38
- PCRX $21.09
- Analyst Decision
- OUST Strong Buy
- PCRX Buy
- Analyst Count
- OUST 7
- PCRX 8
- Target Price
- OUST $17.33
- PCRX $28.38
- AVG Volume (30 Days)
- OUST 2.8M
- PCRX 523.9K
- Earning Date
- OUST 08-07-2025
- PCRX 08-05-2025
- Dividend Yield
- OUST N/A
- PCRX N/A
- EPS Growth
- OUST N/A
- PCRX N/A
- EPS
- OUST N/A
- PCRX N/A
- Revenue
- OUST $117,789,000.00
- PCRX $702,772,000.00
- Revenue This Year
- OUST $32.34
- PCRX $7.90
- Revenue Next Year
- OUST $36.11
- PCRX $11.02
- P/E Ratio
- OUST N/A
- PCRX N/A
- Revenue Growth
- OUST 28.04
- PCRX 3.08
- 52 Week Low
- OUST $5.84
- PCRX $11.16
- 52 Week High
- OUST $31.77
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- OUST 47.51
- PCRX 33.84
- Support Level
- OUST $22.07
- PCRX $21.26
- Resistance Level
- OUST $28.73
- PCRX $22.32
- Average True Range (ATR)
- OUST 2.33
- PCRX 0.83
- MACD
- OUST -0.94
- PCRX -0.04
- Stochastic Oscillator
- OUST 13.51
- PCRX 8.68
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.